This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Borniger, J. C., Walker II, W. H. et al. A role for hypocretin/orexin in metabolic and sleep abnormalities in a mouse model of non-metastatic breast cancer. Cell Metab. https://doi.org/10.1016/j.cmet.2018.04.021 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seton-Rogers, S. Tumours trigger systemic disruption. Nat Rev Cancer 18, 468–469 (2018). https://doi.org/10.1038/s41568-018-0040-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-018-0040-5